Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2015 (2015), Article ID 809289, 10 pages
http://dx.doi.org/10.1155/2015/809289
Review Article

Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical Approach

1Division of Gastroenterology, Case Western Reserve University, School of Medicine, MetroHealth System, 2500 MetroHealth Drive, Cleveland, OH 44109, USA
2Section of Gastroenterology and Hepatology, Temple University Lewis Katz School of Medicine, Temple University Health System, 3440 N. Broad Street, Philadelphia, PA 19140, USA

Received 20 September 2015; Revised 10 November 2015; Accepted 11 November 2015

Academic Editor: Massimiliano Lanzafame

Copyright © 2015 Hicham Khallafi and Kamran Qureshi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Association for the Study of Liver Diseases, “Recommendations for testing, managing, and treating hepatitis C,” 2014, http://www.hcvguidelines.org/full-report-view.
  2. A. I. Tobkes and H. J. Nord, “Liver biopsy: review of methodology and complications,” Digestive Diseases, vol. 13, no. 5, pp. 267–274, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Rockey, S. H. Caldwell, Z. D. Goodman, R. C. Nelson, and A. D. Smith, “Liver biopsy,” Hepatology, vol. 49, no. 3, pp. 1017–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Siddique, H. Abu El-Naga, J. P. Madda, A. Memon, and F. Hasan, “Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection,” Scandinavian Journal of Gastroenterology, vol. 38, no. 4, pp. 427–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Regev, M. Berho, L. J. Jeffers et al., “Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2614–2618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Mehta, B. Lau, N. H. Afdhal, and D. L. Thomas, “Exceeding the limits of liver histology markers,” Journal of Hepatology, vol. 50, no. 1, pp. 36–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. DeLong, D. M. DeLong, and D. L. Clarke-Pearson, “Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach,” Biometrics, vol. 44, no. 3, pp. 837–845, 1988. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  8. European Association for Study of Liver and Asociacion Latinoamericana para el Estudio del Higado, “EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis,” Journal of Hepatology, vol. 63, no. 1, pp. 237–264, 2015. View at Publisher · View at Google Scholar
  9. L. Sandrin, B. Fourquet, J.-M. Hasquenoph et al., “Transient elastography: a new noninvasive method for assessment of hepatic fibrosis,” Ultrasound in Medicine and Biology, vol. 29, no. 12, pp. 1705–1713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Castéra, J. Vergniol, J. Foucher et al., “Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C,” Gastroenterology, vol. 128, no. 2, pp. 343–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Castera, X. Forns, and A. Alberti, “Non-invasive evaluation of liver fibrosis using transient elastography,” Journal of Hepatology, vol. 48, no. 5, pp. 835–847, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Ziol, A. Handra-Luca, A. Kettaneh et al., “Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C,” Hepatology, vol. 41, no. 1, pp. 48–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Degos, P. Perez, B. Roche et al., “Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC Study),” Journal of Hepatology, vol. 53, no. 6, pp. 1013–1021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. H. Afdhal, B. R. Bacon, K. Patel et al., “Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study,” Clinical Gastroenterology and Hepatology, vol. 13, no. 4, pp. 772.e3–779.e3, 2015. View at Publisher · View at Google Scholar
  15. P. Marcellin, M. Ziol, P. Bedossa et al., “Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B,” Liver International, vol. 29, no. 2, pp. 242–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. V. W.-S. Wong, J. Vergniol, G. L.-H. Wong et al., “Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease,” Hepatology, vol. 51, no. 2, pp. 454–462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Steadman, R. P. Myers, L. Leggett et al., “A health technology assessment of transient elastography in adult liver disease,” Canadian Journal of Gastroenterology, vol. 27, no. 3, pp. 149–158, 2013. View at Google Scholar · View at Scopus
  18. J. Vergniol, J. Foucher, E. Terrebonne et al., “Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C,” Gastroenterology, vol. 140, no. 7, pp. 1970–1979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. A. Klibansky, S. H. Mehta, M. Curry, I. Nasser, T. Challies, and N. H. Afdhal, “Transient elastography for predicting clinical outcomes in patients with chronic liver disease,” Journal of Viral Hepatitis, vol. 19, no. 2, pp. e184–e193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Vergniol, J. Boursier, C. Coutzac et al., “Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C,” Hepatology, vol. 60, no. 1, pp. 65–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Castéra, J. Foucher, P.-H. Bernard et al., “Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations,” Hepatology, vol. 51, no. 3, pp. 828–835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. P. Myers, G. Pomier-Layrargues, R. Kirsch et al., “Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients,” Hepatology, vol. 55, no. 1, pp. 199–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Myers, G. Pomier-Layrargues, R. Kirsch et al., “Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe,” Journal of Hepatology, vol. 56, no. 3, pp. 564–570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kettaneh, P. Marcellin, C. Douvin et al., “Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients,” Journal of Hepatology, vol. 46, no. 4, pp. 628–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. E. B. Tapper, E. B. Cohen, K. Patel et al., “Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection,” Clinical Gastroenterology and Hepatology, vol. 10, no. 8, pp. 932.e1–937.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Millonig, F. M. Reimann, S. Friedrich et al., “Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis,” Hepatology, vol. 48, no. 5, pp. 1718–1723, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Lebray, S. Varnous, F. Charlotte, A. Varaut, T. Poynard, and V. Ratziu, “Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency,” Hepatology, vol. 48, no. 6, p. 2089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Arena, M. L. Platon, C. Stasi et al., “Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution,” Hepatology, vol. 58, no. 1, pp. 65–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. P. Myers, M. Elkashab, M. Ma, P. Crotty, and G. Pomier-Layrargues, “Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study,” Canadian Journal of Gastroenterology, vol. 24, no. 11, pp. 661–670, 2010. View at Google Scholar · View at Scopus
  30. J. Boursier, V. de Ledinghen, J.-P. Zarski et al., “Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive,” Hepatology, vol. 55, no. 1, pp. 58–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. H. Afdhal, S. Zeuzem, R. T. Schooley et al., “The new paradigm of hepatitis C therapy: integration of oral therapies into best practices,” Journal of Viral Hepatitis, vol. 20, no. 11, pp. 745–760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Shiratori, F. Imazeki, M. Moriyama et al., “Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy,” Annals of Internal Medicine, vol. 132, no. 7, pp. 517–524, 2000. View at Google Scholar · View at Scopus
  33. A. J. van der Meer, B. J. Veldt, J. J. Feld et al., “Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis,” The Journal of the American Medical Association, vol. 308, no. 24, pp. 2584–2593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Ogawa, N. Furusyo, K. Toyoda, H. Takeoka, S. Maeda, and J. Hayashi, “The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin,” Antiviral Research, vol. 83, no. 2, pp. 127–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Hézode, L. Castéra, F. Roudot-Thoraval et al., “Liver stiffness diminishes with antiviral response in chronic hepatitis C,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 6, pp. 656–663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. D'Ambrosio, A. Aghemo, M. Fraquelli et al., “The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response,” Journal of Hepatology, vol. 59, no. 2, pp. 251–256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. G. L.-H. Wong, H. L.-Y. Chan, P. C.-L. Choi et al., “Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B,” Alimentary Pharmacology and Therapeutics, vol. 39, no. 2, pp. 197–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. G. L.-H. Wong, V. W.-S. Wong, P. C.-L. Choi et al., “Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B,” Journal of Gastroenterology and Hepatology, vol. 24, no. 6, pp. 1002–1007, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Castéra, P.-H. Bernard, B. Le Bail et al., “Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 4, pp. 455–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Maimone, V. Calvaruso, M. Pleguezuelo et al., “An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers,” Journal of Viral Hepatitis, vol. 16, no. 11, pp. 769–774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. H. L.-Y. Chan, G. L.-H. Wong, P. C.-L. Choi et al., “Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B,” Journal of Viral Hepatitis, vol. 16, no. 1, pp. 36–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. V. Papatheodoridis, S. Manolakopoulos, Y.-F. Liaw, and A. Lok, “Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review,” Journal of Hepatology, vol. 57, no. 1, pp. 196–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. L.-H. Wong, V. W.-S. Wong, P. C.-L. Choi et al., “Evaluation of alanine transaminase and hepatitis B Virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography,” American Journal of Gastroenterology, vol. 103, no. 12, pp. 3071–3081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. L.-H. Wong, V. W.-S. Wong, P. C.-L. Choi et al., “Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients,” Clinical Gastroenterology and Hepatology, vol. 7, no. 2, pp. 227–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Marcellin, E. Gane, M. Buti et al., “Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study,” The Lancet, vol. 381, no. 9865, pp. 468–475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Ogawa, N. Furusyo, M. Murata et al., “Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog,” Hepatology Research, vol. 41, no. 12, pp. 1178–1188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. Y.-H. Kuo, S.-N. Lu, C.-H. Chen et al., “The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy,” PLoS ONE, vol. 9, no. 3, Article ID e93160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. G. L.-H. Wong, V. W.-S. Wong, P. C.-L. Choi et al., “On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients,” Antiviral Therapy, vol. 16, no. 2, pp. 165–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. N. Kim, S. U. Kim, B. K. Kim et al., “Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis,” Hepatology, vol. 61, no. 6, pp. 1851–1859, 2015. View at Google Scholar
  50. M. Fraquelli, C. Rigamonti, G. Casazza et al., “Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease,” Gut, vol. 56, no. 7, pp. 968–973, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Ferraioli, C. Tinelli, B. Dal Bello, M. Zicchetti, G. Filice, and C. Filice, “Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study,” Hepatology, vol. 56, no. 6, pp. 2125–2133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Poynard, M. Munteanu, E. Luckina et al., “Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard,” Journal of Hepatology, vol. 58, no. 5, pp. 928–935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Cassinotto, B. Lapuyade, A. Mouries et al., “Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan,” Journal of Hepatology, vol. 61, no. 3, pp. 550–557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Friedrich-Rust, J. Nierhoff, M. Lupsor et al., “Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis,” Journal of Viral Hepatitis, vol. 19, no. 2, pp. e212–e219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Sporea, S. Bota, M. Peck-Radosavljevic et al., “Acoustic radiation force impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study,” European Journal of Radiology, vol. 81, no. 12, pp. 4112–4118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Bota, H. Herkner, I. Sporea et al., “Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis,” Liver International, vol. 33, no. 8, pp. 1138–1147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Nierhoff, A. A. Chávez Ortiz, E. Herrmann, S. Zeuzem, and M. Friedrich-Rust, “The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis,” European Radiology, vol. 23, no. 11, pp. 3040–3053, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. É. Bavu, J.-L. Gennisson, M. Couade et al., “Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients,” Ultrasound in Medicine and Biology, vol. 37, no. 9, pp. 1361–1373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Nightingale, S. McAleavey, and G. Trahey, “Shear-wave generation using acoustic radiation force: in vivo and ex vivo results,” Ultrasound in Medicine and Biology, vol. 29, no. 12, pp. 1715–1723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. M. D. Beland, S. F. Brown, J. T. Machan, R. J. Taliano, K. Promrat, and J. J. Cronan, “A pilot study estimating liver fibrosis with ultrasound shear-wave elastography: does the cause of liver disease or location of measurement affect performance?” American Journal of Roentgenology, vol. 203, no. 3, pp. W267–W273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Bamber, D. Cosgrove, C. F. Dietrich et al., “EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology,” Ultraschall in der Medizin, vol. 34, no. 2, pp. 169–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Manduca, T. E. Oliphant, M. A. Dresner et al., “Magnetic resonance elastography: non-invasive mapping of tissue elasticity,” Medical Image Analysis, vol. 5, no. 4, pp. 237–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. E. C. Ehman, P. J. Rossman, S. A. Kruse, A. V. Sahakian, and K. J. Glaser, “Vibration safety limits for magnetic resonance elastography,” Physics in Medicine and Biology, vol. 53, no. 4, pp. 925–935, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Singh, S. K. Venkatesh, Z. Wang et al., “Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data,” Clinical Gastroenterology and Hepatology, vol. 13, no. 3, pp. 440–451.e6, 2015. View at Google Scholar
  65. Y. Guo, S. Parthasarathy, P. Goyal, R. J. McCarthy, A. C. Larson, and F. H. Miller, “Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis,” Abdominal Imaging, vol. 40, no. 4, pp. 818–834, 2015. View at Publisher · View at Google Scholar · View at Scopus